Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

M Ventures and Novartis Venture Fund co-led a round for the oncology drug startup that also featured fellow corporate venturing unit Pfizer Ventures.

EPFL spinout Lunaphore has received $2m in a series C extension provided by Swiss Entrepreneurs Fund, adding to an initial $23.6m tranche led by PHC Holdings three months ago.

Satt AxLR-allied Phost'in Therapeutics has secured funding to progress cancer drugs targeting glycosylation and the body's immune system.

Lunaphore has received $2m in a series C extension provided by Swiss Entrepreneurs Fund, adding to an initial $23.6m tranche led by PHC Holdings three months ago.

SAP.io returned to help marketing analytics software developer Adverity boost its total funding to $50m, with the latest cash to go to recruitment and R&D.

The dairy cooperative was among the investors in a $16.3m round that will help nutrious drink brand YFood expand further into Europe.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Huntington's disease therapy developer BrainVectis, a spinout of research institute Inserm, has been acquired having disclosed just $1m of equity funding in 2016.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.